Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.
about
Neuropsychological Testing and Machine Learning Distinguish Alzheimer's Disease from Other Causes for Cognitive Impairment.No added diagnostic value of non-phosphorylated tau fraction (p-taurel) in CSF as a biomarker for differential dementia diagnosis.Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update.Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium.Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.Tauopathies: Mechanisms and Therapeutic Strategies.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.A mathematical model of multisite phosphorylation of tau protein.Guanosine Exerts Neuroprotective Effect in an Experimental Model of Acute Ammonia Intoxication.Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration.Cerebrospinal fluid α-synuclein contributes to the differential diagnosis of Alzheimer's disease.Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort.Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis.Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis.
P2860
Q33599831-D3B83852-55BE-4D51-9F6C-3563849F7F2AQ33910641-B299C0A3-BB81-4975-86A1-B1EC9C019B42Q37053871-B8DD70FF-4F41-4722-93B5-EBC1D989E3EAQ37530397-E5B77084-3A69-4814-AF87-9E9F8E0777EBQ38392505-41DDC717-293C-419C-96D9-2B797513378AQ39098473-59C52163-48F4-4B41-904B-7AC79C074307Q39447075-3434017F-434A-4396-B0DD-E1DAFA03B644Q41163005-9B5F92B5-9772-42DB-8AF1-36CE2974834FQ47253592-E615C1EA-5BDA-42FD-B569-8149BB02CC8CQ47587631-78DA4685-622B-49AB-95D0-2EAD93BF4176Q48097704-B1F90946-DB65-4A72-A49A-FB288B7401B9Q52141755-6D761A95-FC16-4309-8EDF-87D14BB04780Q52646410-873BA83E-F2F7-4024-91A9-89E80C3DBB12Q53396870-647ED2BF-6591-4D85-89D7-D916C0D4270FQ53419197-A671778F-DBB1-4561-802B-524923D61C88Q53512696-6A2C6405-E97F-413A-9E0A-B814CBBD4DEAQ55383590-80FD8B1D-FBFB-4658-93E2-A4D24F71FA85
P2860
Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.
@ast
Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.
@en
type
label
Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.
@ast
Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.
@en
prefLabel
Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.
@ast
Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.
@en
P2093
P2860
P356
P1476
Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.
@en
P2093
Ellis Niemantsverdriet
Erik Fransen
Hanne Struyfs
Jean-Jacques Martin
Joery Goossens
Peter P De Deyn
P2860
P356
10.3389/FNEUR.2015.00138
P577
2015-06-17T00:00:00Z